DS
AZN icon

DRW Securities’s AstraZeneca AZN Stock Holding History

DRW Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$107M Buy
542,000
+271,000
+100% +$52.3M 1.48% 12
2025
Q4 		$49.8M Buy
271,000
+208,750
+335% +$36.6M 1.32% 10
2025
Q3 		$9.58M Buy
+62,250
New +$9.42M 0.18% 79
2020
Q4 		– Sell
-4,650
Closed -$510K – 131
2020
Q3 		$510K Buy
+4,650
New +$517K 0.03% 99

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

DRW Securities's AZN Position: Q1 2026 in Review

DRW Securities sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 25,742 shares — an estimated $4.96M sold.

DRW Securities first reported a position in AZN in Q3 2019 and held it in 22 quarters. The position peaked at $12.5M in Q2 2023. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • DRW Securities reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • DRW Securities sold 25,742 AstraZeneca shares in Q1 2026, an estimated $4.96M.
  • DRW Securities first reported a position in AstraZeneca in Q3 2019 and held it in 22 quarters.
  • DRW Securities's AstraZeneca position peaked at $12.5M in Q2 2023.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on DRW Securities's 13F filing for Q1 2026, filed 13 May 2026.